CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a novel treatment for glioblastoma, a highly aggressive brain cancer. Using a machine learning approach, researchers have created a hydrogel-based formulation of a small molecule that shows promise in extending survival and eradicating tumors in animal models, offering a potential one…
Glioblastoma (GBM) is considered the highest unmet need in oncology.
The average life expectancy of GBM patients is 12-18 months, and the 5-year survival rates remain below 7%.
Despite the efforts, the available therapy today counts only with a few (ineffective) approved therapies.Using a machine learning algorithm, we have discovered a correlation between a small molecule and an unexplored target in GBM.
We have developed a hydrogel-based formulation of the molecule with great safety and effica…
TARGTEX SA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
